Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent haemodialysis.
The presence of IgG antibodies against Helicobacter pylori in haemodialysis patients was studied. Furthermore the presence of antibodies in different age cohorts was compared with a population of patients suffering from non-ulcer dyspepsia and healthy blood donors. Antibodies were present in 43% of the haemodialysis patients. In the younger age groups the presence was low compared with the control populations; this difference was not present in the older age cohorts. There was an increasing prevalence of antibodies with rising age. We did not find a correlation between the height of the blood urea levels, before and after haemodialysis, and the presence of antibodies against H. pylori. In conclusion, a high blood urea level does not seem to be a risk factor, per se, for acquiring H. pylori, and the presence of the microorganism probably does not contribute, to a large extent, to the frequent dyspeptic complaints in haemodialysis patients.
Loffeld
R J
RJ
Department of Internal Medicine, University Hospital Maastricht, The Netherlands.
Peltenburg
H G
HG
vd Oever
H
H
Stobberingh
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000907:Antibodies, Bacterial / Q000032:analysis*; D001782:Blood Donors; D015331:Cohort Studies; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis
D000907:Antibodies, Bacterial